Free Trial

Supernus Pharmaceuticals (SUPN) News Today

Supernus Pharmaceuticals logo
$32.15 -0.45 (-1.38%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$32.15 0.00 (0.00%)
As of 05/28/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SUPN Latest News

Supernus Announces Paragraph IV ANDA Filings for Qelbree®
Supernus Pharmaceuticals, Inc. stock logo
Woodline Partners LP Raises Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Woodline Partners LP boosted its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 124.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 423,828 shares of the specialty pharmaceut
Supernus Pharmaceuticals, Inc. stock logo
Point72 Asset Management L.P. Buys Shares of 26,828 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Point72 Asset Management L.P. purchased a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 26,828 shares of the specialty
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Deutsche Bank AG
Deutsche Bank AG grew its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 226.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,583 shares of the specialty pharmaceutical company's
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Systematic Financial Management LP
Systematic Financial Management LP raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 302.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1
Supernus Pharmaceuticals, Inc. stock logo
Captrust Financial Advisors Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Captrust Financial Advisors raised its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 84.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,394 s
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Ameriprise Financial Inc.
Ameriprise Financial Inc. trimmed its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 17.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 450,261 shares of the specialty pharmaceutica
Supernus Pharmaceuticals, Inc. stock logo
Jefferies Financial Group Inc. Buys New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Jefferies Financial Group Inc. bought a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 24,600 shares
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Polar Capital Holdings Plc
Polar Capital Holdings Plc decreased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 12.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687,930 shares
Supernus Pharmaceuticals, Inc. stock logo
D. E. Shaw & Co. Inc. Has $19.73 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
D. E. Shaw & Co. Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 33.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 545,658 shares of the specialty pharm
Supernus Pharmaceuticals, Inc. stock logo
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 103,501 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main cut its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 72.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The inst
Supernus Pharmaceuticals, Inc. stock logo
Centiva Capital LP Acquires New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Centiva Capital LP acquired a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 9,151 shares of the specialty pharmaceutical company's stock, valued at
Supernus Pharmaceuticals, Inc. stock logo
BNP Paribas Financial Markets Buys 208,552 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
BNP Paribas Financial Markets boosted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 248.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 292,629 shares of the
Supernus Pharmaceuticals, Inc. stock logo
Comerica Bank Buys 15,585 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Comerica Bank increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 71.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 37,548 shares of the specialty pharmaceutical company's stock after purchasing an additional 1
Supernus Pharmaceuticals, Inc. stock logo
Schonfeld Strategic Advisors LLC Invests $388,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Schonfeld Strategic Advisors LLC bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,730 shares of the specialty pharmaceutical comp
Supernus Pharmaceuticals, Inc. stock logo
Northern Trust Corp Increases Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Northern Trust Corp boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 18.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 717,161 shares of the specialty pharmaceutical comp
Supernus Pharmaceuticals, Inc. stock logo
Cubist Systematic Strategies LLC Increases Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Cubist Systematic Strategies LLC raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 944.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 139,522 shares
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by First Trust Advisors LP
First Trust Advisors LP lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 48.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,019 shar
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on Wednesday
Supernus Pharmaceuticals (NASDAQ:SUPN) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-supernus-pharmaceuticals-inc-stock/)
Supernus: Q1 Earnings Snapshot
Supernus Pharmaceuticals, Inc. stock logo
Aristotle Capital Boston LLC Sells 118,358 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Aristotle Capital Boston LLC lessened its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,075,868 shares of the specialty pharmaceutic
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stake Raised by PDT Partners LLC
PDT Partners LLC grew its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 48.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 55,008 shares of the specialty ph
Supernus Pharmaceuticals, Inc. stock logo
Hsbc Holdings PLC Sells 22,334 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Hsbc Holdings PLC reduced its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 8.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 228,030 shares of the specialty pharmaceutical company's stock
Supernus Pharmaceuticals, Inc. stock logo
Canada Pension Plan Investment Board Lowers Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Canada Pension Plan Investment Board reduced its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 95.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,700 shares of the specialty pharmaceutical compa
Supernus Pharmaceuticals, Inc. stock logo
Barclays PLC Buys 14,061 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Barclays PLC grew its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 12.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 122,849 shares of the specialty pharmaceutical company's stock after acquiring an addit
Supernus Pharmaceuticals, Inc. stock logo
Wells Fargo & Company MN Boosts Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Wells Fargo & Company MN boosted its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 14.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,237 shares of the specialty pharmaceutical company
Supernus Pharmaceuticals, Inc. stock logo
Raymond James Financial Inc. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Raymond James Financial Inc. bought a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 189,364 shares of the specialty pharmaceutical company's stock, valued
Supernus Pharmaceuticals (SUPN) Receives a Buy from TD Cowen
Supernus Pharmaceuticals, Inc. stock logo
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Gap Up - Here's What Happened
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Gap Up - Here's Why
Supernus Pharmaceuticals, Inc. stock logo
Eversept Partners LP Purchases Shares of 105,581 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Eversept Partners LP purchased a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,581 shares of th
Supernus Pharmaceuticals, Inc. stock logo
Epoch Investment Partners Inc. Increases Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Epoch Investment Partners Inc. lifted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 59.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 85,691 shares of the specialty pharmaceutical comp
Get Supernus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter.

SUPN Media Mentions By Week

SUPN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SUPN
News Sentiment

1.02

0.87

Average
Medical
News Sentiment

SUPN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SUPN Articles
This Week

7

5

SUPN Articles
Average Week

Get Supernus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SUPN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners